ArticleBJOG : an international journal of obstetrics and gynaecology2022
Placenta accreta spectrum - variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study.
Article in BJOG : an international journal of obstetrics and gynaecology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Prophylactic tranexamic acid for the prevention of postpartum haemorrhage in women with placenta praevia: multicentre, double blind, randomised, placebo controlled, phase 3 trial.BMJ (Clinical research ed.) · 2026Trial
- Differential risk and clinical characteristics of placenta accreta spectrum in twin and singleton pregnancies: implications for perinatal outcomes.Journal of global health · 2025Article
- Management and outcomes of women with placenta accreta spectrum grade 3: an INOSS multicountry multiperiod population-based study.BMC pregnancy and childbirth · 2025Article
- Opportunities for, and barriers to, uterus-preserving surgical techniques for placenta accreta spectrum.Acta obstetricia et gynecologica Scandinavica · 2025Article
- New surgical technique for managing placenta accreta spectrum and pilot study of the "CMNT PAS" study.AJOG global reports · 2025Article
- Update on Trends in Placenta Accreta Syndrome and Its Impact on Maternal-Fetal Morbidity in the United States.Women's health reports (New Rochelle, N.Y.) · 2025Article
- Looking back to look forward: Has the time arrived for active management of obstetricians in placenta accreta spectrum?International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025Review
- Single-cell and spatial transcriptomics reveal alterations in trophoblasts at invasion sites and disturbed myometrial immune microenvironment in placenta accreta spectrum disorders.Biomarker research · 2024Article
- A Single-Centre Retrospective Analysis of Pregnancies with Placenta Accreta Spectrum (PAS): From One-Step Surgery towards Two-Step Surgical Approach.Journal of clinical medicine · 2024Article
- Article
- Radiomics-based prediction of FIGO grade for placenta accreta spectrum.European radiology experimental · 2023Article
- Placenta accreta spectrum - the ongoing evolution of an iatrogenic condition.Case reports in women's health · 2023Article
- Placenta accreta spectrum - variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study.BJOG : an international journal of obstetrics and gynaecology · 2022Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
Abstract
objectiveTo compare the management and outcomes of women with placenta accreta spectrum (PAS) in France and the UK.
designTwo population-based cohorts.
settingAll obstetrician-led hospitals in the UK and maternity hospitals in eight French regions. POPULATION: A cohort of 219 women with PAS in France and a cohort of 154 women with PAS in the UK.
methodsThe management and outcomes of women with PAS were compared between the UK and France.
main outcome measuresMedian blood loss, severe postpartum haemorrhage (≥3 l), postpartum infection and damage to surrounding organs.
resultsThe management of PAS differed between the two countries: a larger proportion of women with PAS in the UK had a caesarean hysterectomy compared with France (43% vs 26%, p < 0.001), whereas in France a larger proportion of women with PAS received a uterus-preserving approach compared with the UK (36% vs 19%, p < 0.001). The total median blood loss in the UK was 3 l (IQR 1.7-6.5 l), compared with 1 l (IQR 0.5-2.5 l) in France; more women with PAS had a severe postpartum haemorrhage (PPH) in the UK compared with women with PAS in France (58% vs 21%, p < 0.001) [Correction added on 06 May 2022, after first online publication: '24 hour' has been changed to 'total' in the preceding sentence]. There was no difference between the UK and French populations for postpartum infection or organ damage.
conclusionsThe UK and France have very different approaches to managing PAS, with more women in France receiving a uterine-conserving approach and more women in the UK undergoing caesarean hysterectomy. A life-threatening haemorrhage was more common in the UK than in France, which may be the result of differential management and/or the organisation of the healthcare systems. In women with placenta accreta spectrum, severe haemorrhage was more common in the UK than in France. TWEETABLE ABSTRACT: In women with placenta accreta spectrum, severe haemorrhage was more common in the UK than in France.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.